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Abstract
The ENIGMA group on Generalized Anxiety Disorder (ENIGMA-Anxiety/GAD) is part
of a broader effort to investigate anxiety disorders using imaging and genetic data
across multiple sites worldwide. The group is actively conducting a mega-analysis of a
large number of brain structural scans. In this process, the group was confronted with
many methodological challenges related to study planning and implementation,
between-country transfer of subject-level data, quality control of a considerable
amount of imaging data, and choices related to statistical methods and efficient use
of resources. This report summarizes the background information and rationale for
the various methodological decisions, as well as the approach taken to implement
them. The goal is to document the approach and help guide other research groups
working with large brain imaging data sets as they develop their own analytic pipe-
lines for mega-analyses.
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1 | INTRODUCTION
The ENIGMA (Enhancing NeuroImaging Genetics through Meta Anal-
ysis) Consortium, started in 2009, with the aim of performing large-
scale neuroimaging genetics research using meta-analytic methods by
pooling data from around the world. ENIGMA has since expanded to
include many working groups, resources, and expertise to answer fun-
damental questions in neuroscience, psychiatry, neurology, and genet-
ics (Thompson et al., 2014; Thompson et al., 2020). One of these
groups is the ENIGMA-Anxiety working group, created in 2016 (Bas-
Hoogendam et al., 2020), focused on anxiety related disorders. Such
disorders, that include social anxiety disorder, specific phobia, panic
disorder, generalized anxiety disorder (GAD), and agoraphobia, share
substantive phenomenological features and are often comorbid.
Within the ENIGMA-Anxiety working group, a subgroup devoted to
the study of GAD was formed, the ENIGMA-Anxiety/GAD
“subgroup,” which for simplicity is referred to here as
“ENIGMA-GAD.”
Because the ENIGMA-Anxiety working group was formed rela-
tively recently, it has benefited from the experience and work per-
formed by earlier groups, particularly in terms of collaborative
methods. In more recent years, research groups have become increas-
ingly favorable toward sharing and transferring de-identified individual
participant data (IPD), often as part of cooperative agreements that
respect country-level differences in data privacy and data protection
procedures, discussed below. In the case of ENIGMA-GAD, as
detailed in the final section of this article, the vast majority of sites
contributed raw, T1-weighted magnetic resonance imaging (MRI)
scans, as opposed to processed scans or results of subsequent ana-
lyses. These raw data could then be processed centrally using an
imaging processing software, in this case FreeSurfer1 (Dale, Fischl, &
Sereno, 1999; Fischl et al., 2002; Fischl, Sereno, & Dale, 1999). Having
access to raw IPD provided unique opportunities to review methods
for handling and harmonizing such data, defining processing pipelines,
and implementing analytic strategies. Crucially, this led ENIGMA-GAD
to prioritize a mega-analysis approach. This approach consists of ana-
lyzing IPD from all sites in one stage. This contrasts with two-stage
approaches, which consist of analyzes of site-specific results in a sec-
ond step after each site generates processed data in an initial step
(detailed below).
This paper presents some of the challenges posed by the decision,
by the ENIGMA-GAD group, to use a mega-analysis, and discusses
the rationale for the choices that were made to establish the analysis
plan. The discussion is broadly applicable to mega-analyses in the con-
text of ENIGMA and other international neuroimaging efforts. Below,
differences between meta-analytic vs. mega-analytic approaches, ben-
efits of preregistration, issues concerning data sharing and data reuse
are discussed. Methods for quality control and choices with respect to
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measurements and statistical analyses are also presented. Finally, spe-
cific choices in the ENIGMA-GAD group with respect to each of these
issues are described.
2 | META-ANALYSIS VERSUS MEGA-
ANALYSIS
As collaborative and coordinated endeavors, ENIGMA meta-analyses
studies operate differently from literature-based meta-analyses. In the
latter, results from published studies are compiled to draw conclusions
on a certain question. In most cases, such pooled studies have been
conducted and published over many years, with high sample and
methodological heterogeneity, encompassing diverse statistical
approaches. Such diversity is aggravated in meta-analyses that exam-
ine neuroimaging studies. In neuroimaging studies, substantial chal-
lenges for combined inference result from the use of statistical maps
limited to significant p-values or test statistics, tables with coordinates
in relation to some standard (but not always the same) stereotaxic
space, and different representations of the brain (volume-based or
surface-based; Fox, Lancaster, Laird, & Eickhoff, 2014; Müller
et al., 2018; Tahmasian et al., 2019). Moreover, because of publication
biases, there can be a misrepresentation of negative results (the “file-
drawer” problem; Rosenthal, 1979) or study selection (Roseman
et al., 2011).
In ENIGMA, these issues are minimized through analysis of IPD
using an agreed upon processing strategy. Briefly, three approaches,
that relate to data location, are currently used by different projects
within ENIGMA working groups: (a) all raw data and all derived IPD
remote in relation to the coordinating facility; (b) all raw data remote
in relation to the coordinating facility, but derived data centralized;
(c) all raw data centralized. These approaches are not mutually exclu-
sive within a working group, and different projects conducted by the
same working group may each use a different strategy, depending on
the project goals and considerations about data availability, computa-
tional resources, and expertise. These approaches are summarized
schematically in Figure 1.
For meta-analysis with access to IPD, the strategy includes quality
checks and statistical analysis over mostly coetaneous data. Summary
statistics (such as effect sizes, standard errors, and/or confidence
intervals) are pooled by a coordinating facility that then uses meta-
analytic methods for inference across sites. Such a coordinated, two-
stage meta-analysis approach has been pursued by most ENIGMA
working groups (Hibar et al., 2015; Hibar et al., 2016; Schmaal
et al., 2016; Stein et al., 2012; van Erp et al., 2016), particularly due to
privacy concerns regarding genetic data. ENIGMA genome-wide asso-
ciation studies still use a meta-analysis approach (Hibar et al., 2017;
Satizabal et al., 2019); sites analyze their own data with an agreed
upon protocol, which avoids the need to transfer individual participant
genomic data, and allows distributed analysis of computationally
intense approaches.
Other strategies can be considered if the coordinating facility
has access to all IPD: a single-stage statistical analysis can be
performed by the coordinating facility, while addressing site-
related heterogeneity; this would be a one stage meta-analysis, or
simply “mega-analysis.” With imaging data, such mega-analyses
could start with the raw images being sent to the coordinating
facility where they then undergo batch processing using identical
methods and computing environments. Alternatively, mega-
analyses could start with image-derived measurements, such as
the volumes of brain structures or cortical surface area, already
computed and furnished by the participating sites to the coordi-
nating facility, for each individual participant; the coordinating
facility then proceeds to the statistical analysis. Combination of
approaches for some projects (e.g., some sites sending raw data
for processing whereas others sending processed data) are also
possible.
Analyses using IPD offer several advantages (Riley, Lambert, &
Abo-Zaid, 2010): they improve consistency in inclusion criteria
across sites, better treatment of confounds and of missing data,
verification of assumptions of statistical models, standardization of
procedures, increases in statistical power, reductions in biases for
not depending on previous publications of (invariably significant)
results. Access to IPD further allows other strategies for investiga-
tion that are not limited to hypotheses testing. For example, it may
allow classification at the individual participant level using
machine-learning methods (Nunes et al., 2018). In a mega-analysis
starting with raw imaging data, all data can be processed identi-
cally in the same facility, thus minimizing the chance for errors or
variability that can arise when each site conducts these aspects of
the analysis. One major challenge to this approach is that mega-
analysis requires at least one site to possess the necessary
resources and expertise to handle large datasets. Additionally, this
approach is only possible when IPD are shared with a central facil-
ity. Data exchange on an IPD level often is limited as data protec-
tion is regulated differently among research projects, consortia,
and countries. Barriers on data exchange and limitation of available
resources can, in effect, restrict the participation to few well-
equipped centers.
Multiple studies have compared meta- and mega-analysis (Belias,
Rovers, Reitsma, Debray, & IntHout, 2019; Riley et al., 2010;
Simmonds, Stewart, & Stewart, 2015), suggesting superiority of mega-
analyses with IPD when compared to meta-analyses in terms of higher
statistical power and acceptable false positive rates. In the context of
ENIGMA, comparisons have likewise tended to favor mega-analyses
(Boedhoe et al., 2019; Kochunov et al., 2014; Koshiyama et al., 2020).
However, if individual sites use identical processing strategies with
IPD, a random-effects two-stage approach leads to the same esti-
mates as a (one-stage) mega-analysis. This is well-established in the
neuroimaging literature, which uses similar statistical methods for
multi-level inference for analysis of functional magnetic resonance
imaging data (Beckmann, Jenkinson, & Smith, 2003; Worsley
et al., 2002). Rarely such identical processing can be accomplished,
though, given the usually large number of sites and, and the need that
all engage in approaches intended to ensure consistency (discussed
below).
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3 | ANALYSIS PLAN AND
PREREGISTRATION
Preregistration of clinical trials has been emphasized for many years,
and a registry2 was established by law in the United States through
the Food and Drug Administration Modernization Act of 1997
(Dickersin & Rennie, 2003). Similar registries exist in other countries,
and an international directory was created by the World Health Orga-
nization (WHO), the International Clinical Trials Registry Platform
(ICTRP).3 However, broadly similar efforts did not emerge in other
research areas for decades. Defining a hypothesis, an associated anal-
ysis plan, and preregistering these ideas before conducting any ana-
lyses is important in many ways (Chambers, 2013). It helps to
conceptually separate specific, previously formulated hypotheses
F IGURE 1 Differences between classical, literature-based meta-analyses, conducted without access to individual participant data (IPD) (upper
panel) versus approaches used by different ENIGMA working groups, in which researchers, collectively, have access to IPD (lower panel). The
latter encompasses three main approaches (top) data are processed using common methods at each site, then summary statistics are computed
and sent to a coordinating facility which then conducts a meta-analysis; (middle) data are processed using common methods at each site, then
sent to the coordinating facility which then conducts a mega-analysis; and (bottom) raw data are sent to the coordinating facility which then
processes the data in batch and conducts a mega-analysis, while taking site-specific effects into account
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from exploratory analyses that have potential to generate new
hypotheses based on the data (Nosek, Ebersole, DeHaven, &
Mellor, 2018; Wagenmakers, Wetzels, Borsboom, van der Maas, &
Kievit, 2012). Likewise, it helps to separate a priori and exploratory
hypotheses and the analytic plans used for their investigation
(Ledgerwood, 2018). The benefits, however, stretch well beyond epis-
temological advantages by reducing the potential for questionable
research practices (Chambers, Feredoes, Muthukumaraswamy, &
Etchells, 2014). For example, preregistration reduces problems that
follow when negative results remain unreported (Rosenthal, 1979;
Sterling, 1959), reduces the chances of selective reporting (Macleod
et al., 2014) and maximizes transparency in analytic approaches,
thereby facilitating replication (Simmons, Nelson, &
Simonsohn, 2011). Without preregistration, these problems remain
prevalent, possibly due to the structure of incentives in academic
environments (Neuroskeptic, 2012; Nosek, Spies, & Motyl, 2012). Pre-
registration also reduces hypothesizing after the results are known
(Kerr, 1998), and protects scientists from other biases
(Chambers, 2013), such as confirmation bias, hindsight bias, and
anchoring effects (Moreau, 2019).
For ENIGMA, specific details and challenges need to be consid-
ered when preregistering a study. First, an analytic plan must be dis-
cussed with participating centers. The plan should include who access
the data, roles of each participating site and their personnel, compli-
ance with supervening laws and regulations, funding sources, as well
as authorship expectation. This ensures that pooled data from differ-
ent cohorts are analyzed in a way acceptable by all investigators. Sec-
ond, many ENIGMA sites may have already analyzed the data they
share for meta or mega-analysis, often to test similar hypotheses as
those being considered for the ENIGMA combined analyses.
Obtaining credible results requires an analytic plan free of influences
from findings known by the investigators, and that remains inclusive
of all relevant data. Preregistration mitigates such concerns by
supporting reasonable hypotheses of broad interest and with well-
defined inclusion and exclusion criteria of subjects, both of which are
unlikely to be swayed by prior knowledge of outcomes. These analytic
plans are formalized into “project proposals,” which can be distributed
to members for approval and participation, and are often considered a
form of preregistration for working group members.
Many platforms support preregistration, though the platform pro-
vided by the Open Science Foundation4 stands out for its comprehen-
siveness and user-friendliness. The process is remarkably simple, with
the site offering detailed instructions and preregistration templates.
Specifying an embargo period before the registration becomes public
is possible, and a digital object identifier (DOI) can be generated.
4 | DATA SHARING AND REUSE
Both meta- and mega-analysis require that individual sites transfer
data to the coordinating facility. Aggregated data, such as histograms
of quality metrics, effect sizes, confidence intervals, and standard
errors, are not identifiable at the individual level and can be
transferred parsimoniously among sites without substantive risk of
reidentification. It should be noted, however, that without precaution-
ary measures, repeated computation of aggregate results using slightly
varying subsets of participants can expose information about individ-
uals (Dwork, 2006). This risk can be minimized through agreements
among researchers on the nature and amount of aggregated data to
be transferred. For mega-analyses, in which IPD are transferred, fur-
ther attention is needed, due to differences across sites in the regula-
tions that protect the confidentiality, integrity, and security of the IPD
and their use in human research. In international collaborations, such
as ENIGMA, accommodating such requirements necessitates that the
strictest regulations are followed. While compliance with the law must
be integral, three points are particularly relevant for ENIGMA projects:
(a) protection of data and privacy of research subjects, (b) data reuse,
and (c) international transfers of data.
In the United States (US), research must follow the Federal Policy
for the Protection of Human Subjects (the “Common Rule”; Arellano,
Dai, Wang, Jiang, & Ohno-Machado, 2018). This requires that specific
consent be obtained from participants before their data and/or speci-
mens can be used not only for the research project for which they are
enrolling, but also for future research that may use such material,
which often is the case of ENIGMA projects. Privacy in the US is
governed by the Health Insurance Portability and Accountability Act
(HIPAA) of 1996, which requires patient data to be de-identified;
reuse requires approval by an Institutional Review Board.
Regulations differ, however, across countries. In the US, there is a
presumption that processing personal data is lawful unless it is
expressly forbidden. In the European Union (EU), in contrast, the
processing of such data is prohibited unless there is a lawful basis that
permits it (Dove, 2018). Legal provision for data protection and use in
research comes from the General Data Protection Regulation (GDPR),
adopted in 2016, which also covers the use of data from EU residents
outside the Union (Chassang, 2017). While HIPAA emphasizes subject
privacy, the GDPR makes no direct mention of privacy whatsoever,
dealing instead with data protection, as established in the EU Charter
of Fundamental Rights along with the right to a private life. Privacy is
extremely difficult to define (Alfino & Mayes, 2003), and may be
understood in this context as a state of nonaccess to data pertaining
to an individual (Dove, 2018). Data protection, in turn, is a less ambig-
uous definition and can be understood as a set of rules that aim to
protect the rights, freedoms, and interests of individuals whose per-
sonal data are handled and used (Tzanou, 2013).
The GDPR establishes that data reuse should only be allowed
where new purposes are compatible with those for which the data
were initially collected. This is usually the case for ENIGMA analyses.
International data transfers are not allowed unless the country to
which data are sent has been found by the European Commission to
provide “adequate” data protection; at the time of this writing, the list
of countries for which an adequacy decision has been provided
includes, for example, Argentina, Israel, Japan, New Zealand, and Swit-
zerland.5 While the list does include the US and Canada, in the case of
these two it does so for commercial uses of data that do not broadly
cover research by universities and research institutes as needed for
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ENIGMA. In the absence of such adequacy decision, or of specific der-
ogations, an alternative path to data transfer is through specific provi-
sion of safeguards concerning data protection. These require the
signing of legally binding agreements between authorities, or binding
corporate or institutional rules approved by competent supervisory
authorities (Dove, 2018; Staunton, Slokenberga, & Mascalzoni, 2019).
If none of these paths are viable, a possible solution to still allow
research is to determine that the coordinating facility for a given
ENIGMA Working Group will be in the EU itself; then no data from
EU subjects need to be transferred to outside the Union. However,
such a workaround is limited in scope and time: countries that are in
the process of adopting legislation modeled after GDPR (such as the
United Kingdom through the Data Protection Act of 2018) will be
under broadly similar rules; these countries might, nonetheless,
quickly receive an adequacy decision by the European Commission,
such that transfers between the EU and these countries should ulti-
mately be facilitated.
4.1 | De-identification
Regardless of specific legislation, data de-identification is a crucial
step. De-identification consists of removal of personally identifiable
information that allows data to be traced back to individuals, thus ren-
dering such identification impossible or extremely difficult or unlikely.
In the context of HIPAA, unless otherwise determined by an expert,
removal of information such as names, locations with granularity
smaller than that of a state, dates related to an individual (such as
birth date, admission date, etc.), and other identifying details, is con-
sidered to provide a reasonable basis to assume that the information
cannot be used to identify an individual. Full-face photographs and
any comparable images must likewise be removed for HIPAA compli-
ance. For ENIGMA data, this means that MRI scans may need to have
facial features of subjects removed before data are shared (see
below).
Unlike HIPAA, the GDPR does not specify de-identification
methods. Instead, researchers are expected to remain mindful that de-
identified data might become reidentifiable through the development
of new technologies or use of ancillary data. Thus, the GDPR requires
vigilance to ensure that data remain anonymous (Dove, 2018). Manag-
ing the risk of reidentification is crucial, and safeguards should be put
in place as if the data were not anonymous. Pseudonymized
(e.g., tokenized or key-coded) data are subject to the GDPR, even if
the codes are not shared and remain within different organizations.
For ENIGMA, this means that sites that handle information of EU resi-
dents must ensure complete de-identification as well as take into
account the risk that de-identified data becomes reidentifiable, or pur-
sue GDPR compliance by treating data as if not anonymous.
Imaging data stored in the standard Digital Imaging and Commu-
nications in Medicine (DICOM) file format are accompanied by a host
of personally identifiable information. Tools exist to anonymize such
files, by erasing fields from the file header that could contain such
information. Another popular file format used in brain imaging is the
Neuroimaging Informatics Technology Initiative (NIFTI). This format
stores no personally identifiable information but contains two
general-purpose fields (“descrip” and “intent_name,” with 80 and
16 bytes, respectively) that could hold such information. The format
can also accommodate extensions, and can be paired with a JavaScript
Object Notation text file (JSON), both of which may contain informa-
tion that may allow subject identification. Any field with information
that could lead to reidentification must be erased or removed before
data can be shared between ENIGMA sites and the coordinating facil-
ity, or other safeguards must be in place to ensure no reidentification
will be attempted or possible. A popular tool for conversion from
DICOM to NIFTI, “dcm2niix” (Rorden, 2014) allows removal of such
information during format conversion.
Moreover, the data portion of DICOM and NIFTI files may be
edited to ensure that facial features will be removed (defacing).
Reidentification of participants based on scan data had been consid-
ered a remote possibility, which motivated the creation of defacing
algorithms (Alfaro-Almagro et al., 2018; Bischoff-Grethe et al., 2007;
Milchenko & Marcus, 2013; Schimke, Kuehler, & Hale, 2011). Such
reidentification, however, has recently been demonstrated to be feasi-
ble (Schwarz et al., 2019), which now renders defacing mandatory for
publicly available data. Moreover, two recent developments further
complicate matters. First, even defaced data may be reidentified, par-
ticularly if facial features are only blurred, as opposed to completely
removed (Abramian & Eklund, 2019). Second, recent research indi-
cates that defacing unfortunately may degrade the performance of
image processing algorithms, possibly affecting the quality of mea-
surements obtained (de Sitter et al., 2020). For ENIGMA mega-ana-
lyses, reconciling data protection with maximum scientific value that
data can provide may ultimately require bilateral agreements to avoid
data breaches that could allow for unintended or malicious use. In this
case the participating institutions can reach an understanding (usually
in the terms of a data use agreement—DUA) that all shared data is to
remain securely stored with limited access to researchers who are
conducting relevant ENIGMA work.
4.2 | Encryption and transfer
Encryption reduces the possibility that data might be misappropriated
when stored, or intercepted during transfer, and thus reduces the
chances that data can be used in ways that are not in the best interest
of research participants. Data encryption is always compatible with
both HIPAA and GDPR, and in the case of the former, it can be con-
sidered “a reasonable and appropriate measure” to ensure confidenti-
ality, which renders it mandatory for all practical purposes. Even
without specific regulations, data encryption is good practice insofar
as the confidentiality, integrity, and security of data of participants are
concerned.
A basic scheme consists of encrypting the data using a reasonably
secure cipher (algorithm), with a key (password) that can also be used
for decrypting. Such a key is transmitted from an individual site to the
ENIGMA coordinating facility through means other than those used
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to transfer the encrypted data. A more sophisticated approach uses
pairs of public/private keys: the site encrypts the data using the public
(not secret) key provided by the coordinating facility; data can be
decrypted by the coordinating facility using the private (secret) key.
Various tools enable encryption of individual files or the generation of
encrypted containers, which are files that emulate a file system and
can hold multiple other files. Examples of such tools that operate
across multiple platforms include VeraCrypt,6 CipherShed,7 and
GnuPG.8
Data transfer can be performed in different ways: if data are
strongly encrypted, transmission does not require further encryption;
if data are not encrypted, transmission should use a form of secure
communication. For small amounts of data, such as for analyses using
imaging-derived measurements, which tend to be smaller than with
imaging data in full resolution, a plain email with encrypted attach-
ments containing the (possibly compressed) data, or encrypted emails
with nonencrypted attachments, are sufficient. For large volumes of
data, as for mega-analyses that start from raw data, data transfer
using methods such as SSH file transfer protocol (SFTP) are more con-
venient. However, connection to institutional servers (or even per-
sonal laptops) hosting the data may require the potentially
problematic opening of firewall exceptions. Two alternative methods
are straightforward to implement. One uses strong ciphers to encrypt
the data, which are then stored in a physical portable medium, such as
external hard drives, thumbsticks, or even secure digital (SD) cards, to
be sent by post or courier; decryption keys are negotiated ahead of
time and shared through different means. The second method uses
peer-to-peer secure transfers using a service such as Globus,9 a non-
profit, free service provided by the University of Chicago
(Ananthakrishnan, Chard, Foster, & Tuecke, 2015) for data exchange
among academic or research institutions.
Cloud storage systems (e.g., Dropbox,10 Box,11 Amazon Web
Services,12 Google Drive,13 and Microsoft Azure14) should be used
with caution. Even though most cloud providers offer some level of
encryption, compliance with data protection and privacy laws may
only be offered with high tier subscriptions or specific security set-
tings, if offered at all. Users should be aware of the level of compli-
ance that their choice of cloud system provides.
Encryption and transfer have sometimes to be established on a
site-specific basis. Some sites may have particular expertise and/or
infrastructure in place to allow transfer of large amounts of data using
particular methods, which would be favored over others. Laws
governing transfer of technology and geopolitics may also impact
choices: furnishing encryption software to some countries is illegal in
some jurisdictions, whereas receiving hard drives may also pose diffi-
culties in countries that heavily tax or delay the delivery of imported
goods.
4.3 | Organization and processing
Before or after being transferred to the coordinating facility, the data
can be organized into a scheme that facilitates processing and the use
of imaging pipelines, such as the brain imaging data structure (BIDS;
Gorgolewski et al., 2016). BIDS prescribes a hierarchy of files and
directories that is simple and intuitive, yet powerful enough to accom-
modate a diverse set of imaging modalities collected in varied circum-
stances. The scheme is intended to minimize efforts related to data
curation, to reduce the number of errors due to incorrect organization
of data files, and to facilitate the development and usage of software,
which can be written to parse the file structure directly (Gorgolewski,
Alfaro-Almagro, Auer, Bellec, & Capot, 2017).
Processing of the whole dataset using one operating system and
software version can help avoid inconsistencies. It has been demon-
strated that differences in operating systems can have a small effect
on, for example, FreeSurfer metrics (Gronenschild et al., 2012); such
metrics have been used in many ENIGMA analyses to date, including
in ENIGMA-GAD analyses. Scientists may benefit from monitoring
their computing environment and run analyses in batches that are not
interspersed with periodic software updates.
Options to ensure software consistency include the use of virtual
machines (such as QEMU/KVM,15 VirtualBox,16 or VMware17) or con-
tainerized environments (such as Docker18 or Singularity19). In virtual
machines, the whole system—including emulated hardware and the
“guest” operating system—can be kept static and be shared. Con-
tainers use a layer of compatibility between the “host” operating sys-
tem and the desired applications. They tend to run faster and have
simpler maintenance than virtual machines. In either case, the
researcher can keep tight control over software versions, libraries, and
dependencies. Neither of the two methods, however, is ideal. Virtual
machines can be heavier to run and offer less flexible integration with
the host operating system (which in turn may have access to a large
computing cluster, such that integration is something often desirable).
Containers address this problem but introduce others: troubleshoot-
ing experimental software may be difficult because it is not always
clear whether a given problem has arisen because of the software
itself, or because of the container or its interaction with the host sys-
tem. Regardless, such solutions improve reproducibility of results by
allowing researchers to share not only their code and information
about their computing environment, but also their actual computing
environment.
5 | QUALITY CONTROL
For ENIGMA meta-analyses, each site can perform a quality assess-
ment of its own data using a previously agreed protocol. Sites can
report the quality metrics to the coordinating facility, which then can
use the information in the statistical model by, for example, giving less
weight to sites contributing lower-quality data. ENIGMA protocols
provide consistent, streamlined strategies for visual inspection of
imaging data; these strategies involve inspection of the cortical border
between gray and white matter, parcellations of the cortex, and seg-
mentation of subcortical structures. For mega-analyses, while the
same kind of visual inspection could be advantageous, the amount of
data may render this process difficult. Although there is no standard
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triage or similar requirement before sharing raw data, it is usually the
case that images will have already been seen by at least one investiga-
tor before sharing, and as such, might have been excluded from con-
sideration and not sent to the coordinating facility. Moreover, while
using the same raters may give higher consistency on selection of par-
ticipants across sites given imaging features, the same process might
introduce unwanted bias toward selection, for example, if imaging fea-
tures used to visually define inclusion or exclusion are unknowingly
related to the variables investigated, a risk that may be present even if
quality criteria are consistent across sites.
5.1 | Automated methods
Biases arising from manual inspection can be minimized through auto-
mated quality control methods. In the UK Biobank, for example, a
supervised learning classifier identifies problematic images with
acceptable accuracy (Alfaro-Almagro et al., 2018). The UK Biobank,
however, benefits from the fact that data collection is limited to only
three sites, all of which use identical equipment (Miller et al., 2016). In
ENIGMA, data come from many sites, with MRI scanners from differ-
ent vendors and models, with different field and gradient strengths,
different coils, acquisition sequences, and software versions. Using a
quality control classifier with such heterogeneous data is challenging
(Chen et al., 2014; Focke et al., 2011; Han et al., 2006; Jovicich
et al., 2006), although methods with good performance have been
proposed (Klapwijk, van de Kamp, van der Meulen, Peters, &
Wierenga, 2019).
Tools such PCP-QAP20 (Zarrar et al., 2015) and MRIQC21
(Esteban et al., 2017) compute a host of image quality metrics that
consider signal, noise, image smoothness and contrast, as well as spe-
cific artifacts (Atkinson, Hill, Stoyle, Summers, & Keevil, 1997; Die-
trich, Raya, Reeder, Reiser, & Schoenberg, 2007; Ganzetti,
Wenderoth, & Mantini, 2016; Magnotta & Friedman, 2006; Mortamet
et al., 2009). In particular, MRIQC operates on data organized
according to BIDS, and produces detailed reports of these metrics.
This tool does not, however, classify images as having high or low
quality; instead, it provides an interface for a rater to make that deter-
mination based on the computed quality metrics and possibly other
features; these metrics may, in turn, be used to train a classifier. Such
classification, however, can be difficult to generalize, given the diver-
sity of data from multiple sites (Esteban et al., 2017). Even so, derived
metrics may be insufficient to predict successful generation of cortical
surfaces and segmentation of subcortical structures with FreeSurfer,
from which image-derived measurements of interest are often com-
puted. Notwithstanding these considerations, it is good practice to
investigate quality using this kind of tool, which includes boxplots
(Figure 2), and mosaics that show multiple slices color-coded so as to
highlight potential defects. The output from these tools are useful to
assist in flagging images that, even if successful at FreeSurfer
processing, may require specific decisions whether or not they should
remain in the sample. Moreover, these tools provide summary metrics
that can be returned to the contributing sites, where local researchers
can assess the quality of their own images versus those collected by
others or elsewhere (Esteban et al., 2019).
5.2 | Euler characteristic
One particular metric has been found to be a good predictor of the
quality of FreeSurfer outputs: the Euler characteristic (χ; sometimes
also called Euler number) of the cortical surface produced before
topological correction (Rosen et al., 2018). To conceptualize the Euler
characteristic, consider a polyhedron whose spatial configuration is
determined by its vertices, edges, and faces. It can be shown
(Lakatos, 1976) that if the polyhedron is convex, the number of verti-
ces (V), minus the number of edges (E), plus the number of faces (F), is
always equal to 2; this quantity is the Euler characteristic, that is,
χ = V − E + F. If the polyhedron is crossed by a single hole, χ is
decreased by 1; if crossed by two holes, decreased by 2; if hollow, χ is
increased by 1. More generally, for every hole that crosses a polyhe-
dron, its χ is decreased by one, whereas for every hollow, it is
increased by one. The Euler characteristic is well-known in neuroim-
aging as a key metric for multiple-testing correction using the random
field theory (RFT; Worsley et al., 1996). Here, however, it serves an
entirely different purpose: it acts as a metric to quantify topological
deviation of the initial cortical surface from a sphere, as an increas-
ingly large number of holes in the initial surface generates an increas-
ingly negative Euler characteristic. As these values become more
negative, the more likely it is that the original T1-weighted scans had
low quality in ways that negatively impacts the surface reconstruction.
FreeSurfer treats such holes as topological defects and corrects them
automatically to create a cortical surface that reaches a χ = 2 (Fischl,
Liu, & Dale, 2001). However, initial surfaces that have too many
defects are less likely to be ever usable, even after topology
correction.
The Euler characteristic was found to be highly correlated with
manual quality ratings, discriminating accurately unusable from usable
scans, and outperforming other data quality measures (Klapwijk
et al., 2019). However, the precise threshold to be applied to χ
remains unknown when deciding whether a surface is usable or not;
such a threshold may be site or scanner specific. Moreover, it is not
currently known whether, as a general rule, the Euler characteristics
for each brain hemisphere should be combined as their mean, or the
worst (minimum, most negative) of the two, nor whether other met-
rics related to surface topology could be helpful for quality assess-
ment. For subcortical structures, specific quality metrics are currently
missing from the literature.
5.3 | Manual edits
Image processing pipelines may allow manual edits when automated
approaches fail to generate processed images of desirable quality. This
is also the case with FreeSurfer, whereby the user can employ “con-
trol points” to establish final cortical surface placements;
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segmentation also can be hand edited to exclude nonbrain tissue and
fix mislabeled regions. Different ENIGMA working groups have
decided differently on whether or not to do manual editing, as the
process is time consuming and requires expert knowledge. Crucially,
while manual editing may improve validity of measurements, it intro-
duces variance to the data unrelated to the images themselves, but
related to the manual operator; multiple operators potentially com-
pound the problem. Taken to an extreme, such undesired variance can
reduce power, though research has found that such editing may have
little impact on the final results, in either a beneficial or deleterious
manner (McCarthy et al., 2015).
6 | MEASUREMENTS
Imaging generates a myriad of measurements. Analyses can reveal
genetic and environmental influences on healthy and pathological var-
iability in the human brain, providing great potential currently not fully
harnessed. As an example, a recent ENIGMA meta-analysis using data
from 51,665 subjects identified 187 loci influencing cortical surface
area and 12 others influencing thickness (Grasby et al., 2020); in
another example, the recent UK Biobank analysis used 3,144 imaging-
derived traits (Elliott et al., 2018) to find 148 replicable clusters of
associations between single nucleotide polymorphisms and these
traits. Not all imaging traits are sufficiently well defined and stable to
allow reliable quantification for ENIGMA meta or mega-analyses,
though. While the problem can be partially mitigated in mega-analyses
that use common processing schemes, stable, reliable measurements
should be the first line of research. Region-based or vertex-based
measures of cortical thickness, cortical surface area, and cortical and
subcortical volumes are easily obtained, and measurement workflows
are established across multiple research sites (Hibar et al., 2015; Stein
et al., 2012; Thompson et al., 2014). Diffusion-weighted imaging also
allows measurements that are robust to variations on processing pipe-
lines, and workflows for ENIGMA have been developed (Jahanshad
et al., 2013; Kochunov et al., 2015). Likewise, a resting-state
F IGURE 2 Example screenshot of a report of image quality for the subjects of one site. Box plots of various metrics are shown. The report is
produced by the tool MRIQC, available, along with documentation that details all the metrics (many more than shown in the figure), at https://
mriqc.readthedocs.io
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functional MRI processing pipeline was proposed recently for use in
ENIGMA meta-analyses (Adhikari et al., 2018).
The goal of these pipelines is to ensure consistency in methods
across sites, not affecting the relationship between the imaging mea-
surements and their underlying biological processes. In effect, such
measurements may be influenced by a myriad of physiological and
pathological processes. For cortical thickness and surface area, for
example, measurements depend to some extent on neuronal and glial
cell volume and density, dendritic complexity, degree of myelination,
inflammatory processes, and other factors. Evidence has been
reported for changes in cortical thickness associated with learning
(Zatorre, Fields, & Johansen-Berg, 2012) and even with stimuli during
structural MRI data collection (Månsson et al., 2020); the latter find-
ing, if confirmed, could indicate that information about what the sub-
jects viewed would need to be considered as a confound at the time
of the statistical analysis.
Furthermore, the scale with which measurements are obtained
does not necessarily correspond to the scale in which linear effects
manifest; such linear effects constitute the backbone of most statisti-
cal brain-imaging analyses as encapsulated in the general linear model
(GLM). The GLM assumes that modeled factors (e.g., diagnostic group,
age, and sex) possess additive effects over the dependent variable
(e.g., an imaging-derived measurement); this may not always hold.
Some notable examples include fine-resolution area of the cortex,
which follows a lognormal distribution potentially reflecting exponen-
tial influences; fractional anisotropy of water diffusion, a quantity
bounded between 0 and 1, also could be considered not a sum of mul-
tiple small effects, nor functional connectivity assessments bounded
between −1 and 1. Cases such as these may be accommodated
through the use of a data transformation, such as logarithmic, power,
Fisher's r-to-z, logit, or probit transformations; generalized linear
models and nonparametric statistics can also be considered.
6.1 | Choice of resolution
Researchers need to consider whether imaging analyses should use
measures obtained at every point of an image (e.g., voxelwise or
vertexwise data) or aggregate measures computed over regions of
interest or parcellations, broadly termed as “ROIs.” Although
vertexwise analyses have been performed in recent ENIGMA research
(Chye et al., in press; Ho et al., 2020), most previous ENIGMA studies
used meta-analyses. In these cases, an ROI-based approach is more
robust to small deviations from a common image registration scheme.
Moreover, voxelwise and vertexwise measurements represent small
pieces of tissue in relation to the resolution inherent to the equipment
or scanning sequence. As such, these measures are intrinsically noisier
than ROI-based quantities. Furthermore, because the number of
voxels/vertices is usually many times larger than the number of ROIs
under potential consideration, their use is computationally more
intensive, and leads to an exacerbation of the multiple testing
problem.
These considerations, however, do not imply superiority of ROI-
based measurements over voxelwise or vertexwise approaches. While
noisier, vertexwise and voxelwise data are typically smoothed,
thereby increasing the signal-to-noise ratio while retaining localizing
power. Moreover, statistical power of ROI-based measurements is
maximal when the space spanned by the true effects matches per-
fectly the borders of the ROI; otherwise, true signal is diluted within
an ROI, or split across multiple ROIs. Multiplicity of testing, while
more severe with voxelwise or vertexwise data, may not necessarily
compromise power: the tests are largely nonindependent and
methods to accommodate such nonindependence exist, both in para-
metric (Worsley et al., 1996) and nonparametric cases (Winkler, Web-
ster, et al., 2016). Finally, it is not always obvious how to aggregate
measurements for ROIs, nor what the ROIs should be. For example,
while the surface area of an ROI can be trivially obtained by summing
together the areas assigned to all vertices within that region, thickness
within the same ROI could be computed either as an average of all
vertices, or as a weighted average using the areas of the vertices as
weighting factor; for functional MRI, aggregate measurements could
be the simple average, or the first principal component. Moreover, a
host of different parcellation schemes exist (Craddock, James,
Holtzheimer, Hu, & Mayberg, 2012; Desikan et al., 2006; Destrieux,
Fischl, Dale, & Halgren, 2010; Glasser et al., 2016; Ji et al., 2019; Mag-
gioni, Tana, Arrigoni, Zucca, & Bianchi, 2014; Power et al., 2011;
Schaefer et al., 2018; Tzourio-Mazoyer et al., 2002; Yeo et al., 2011),
based on various macroscopic, microscopic, and functional aspects of
the brain, none of which is clearly superior to others for all possible
investigations (Arslan et al., 2018; Brett, Johnsrude, & Owen, 2002;
Messé, 2019). For instance, the use of an anatomical parcellation in
fMRI studies might hide possibly relevant functional inhomogeneities
within each cluster (Maggioni et al., 2014).
Pooling raw IPD for mega-analysis creates many data analytic
opportunities. Since the coordinating facility has access to all data,
mass-univariate analyses are possible without the constraints imposed
by the limited data exchanges of meta-analyses. Mass-univariate
methods support easier, more reliable forms of vertexwise/voxelwise
analyses, performed by processing all data in an identical manner,
regardless of site provenance, an approach that has already been used
in ENIGMA (Wang et al., 2019). However, this process still can be
computationally difficult. FreeSurfer default surface data, for example,
uses 163,842 vertices per hemisphere for between-subject compari-
sons, which is denser than the number of voxels that pass through the
pia mater or the interface between gray and white matter in a typical
MRI scan, given the cortical convolutions; moreover, data are usually
smoothed, further lowering the effective resolution. Computational
savings that do not substantively sacrifice localizing power may be
accomplished by downsampling the surface. In the case of FreeSurfer,
this downsampling can be done by using an icosahedron recursively
subdivided fewer times (n) than the default 7 (Winkler et al., 2012,
appendix A) as the target for interpolation. Data from vertices not
explicitly included are still represented when smoothing is applied
before interpolation, thus before downsampling. The number of
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vertices is given by V = 10  4n + 2 if the grid is based on an icosahe-
dron; using n = 4 or 5 still allows good cortical coverage (Figure 3).
6.2 | Harmonization
In a mega-analysis, pooling data from numerous cohorts requires
addressing nuisance factors. Site, scanner and cohort-specific effects
of no interest can be manifest as effects larger than diagnosis or other
effects of interest; neglecting such nuisance effects can reduce power
or generate false positives and low reproducibility (Baggerly,
Coombes, & Neeley, 2008; Leek et al., 2010). These confounds can be
accommodated at the time of the statistical modeling and analysis, at
the penalty of increasing model complexity, or the data may be modi-
fied before analysis so as to remove such unwanted effects.
ComBat (“combining batches”) is such an approach, that allows
harmonization of data across sites. The method originated in genetics
for correcting batch effects in microarrays, and is described in detail in
F IGURE 3 Surface reconstructions of the cortex of the right hemisphere based on different resolutions of a recursively subdivided
icosahedron. The default in FreeSurfer uses n = 7 recursions, resulting in a total of 163,842 vertices. Considerable computational savings can be
obtained with lower resolutions (such as with n = 4 or 5) without substantial losses in localizing power. V, number of vertices; E, number of edges;
F, number of triangular faces
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(Johnson, Li, & Rabinovic, 2007). In brief, ComBat incorporates sys-
tematic biases common across voxels/vertices, under the mild
assumption that phenomena resulting in such “batch” effects
(e.g., site, scanner, and/or cohort effects) affect voxels/vertices in sim-
ilar ways (e.g., stronger mean values, higher variability). In the method,
location (additive) and scale (multiplicative) model parameters that
represent these batch effects are estimated. This estimation is done
by pooling information across voxels or vertices from participants
from each site so as to shrink such unwanted effects toward an over-
all group effect (i.e., across batches and voxels/vertices). These esti-
mates are then used to adjust the data, robustly discounting
unwanted effects. Variability of interest or related to known nuisance
or confounds (e.g., age or sex) can be retained. In brain imaging, the
approach has been an effective method to harmonize diffusion tensor
imaging data (Fortin et al., 2017), cortical thickness measures (Fortin
et al., 2018), rest and task-based functional MRI (Nielson et al., 2018),
and functional connectivity (Yu et al., 2018). ComBat has been used in
ENIGMA studies (Hatton et al., in press; Villalón-Reina et al., in press),
although it has been argued that it leads to similar results as random
effects linear regression (Zavaliangos-Petropulu et al., 2019). Which
statistical harmonization model is optimal remains an active discussion
at the time of this writing.
7 | STATISTICAL ANALYSIS
Statistical analyses can proceed once data have been processed, and
measurements obtained and possibly harmonized. Such analyses esti-
mate the effects of interest and compare them to expected observa-
tions should there be no real effect to compute a p-value. It is at the
stage of the statistical analysis that the differences between meta-
and mega-analysis become most pronounced.
7.1 | Fixed versus random effects
For all cases discussed in Figure 1, analyses may assume that true
effects are fixed (constant) across sites, and therefore any differences
in effects among sites are solely due to random experimental error, or
may assume that the true effects themselves may be random
(i.e., varying) across sites. For meta-analyses without access to IPD,
the above distinction between fixed and random effects holds rela-
tively without ambiguity, and distinct methods to summarize literature
findings for either of the two cases exist (Borenstein, Hedges,
Higgins, & Rothstein, 2009). For other cases, unfortunately, these
terms have multiple meanings that sometimes conflict
(Gelman, 2005). For research using IPD, less ambiguous definitions
apply to slopes and intercepts, which can be treated as constant (thus,
fixed) or allowed to vary (thus, random) across sites. This distinction
between fixed and random becomes then an attribute not of the sta-
tistical model, but of each independent variable.
As for the level of inference, in the case of ENIGMA, the selection
of sites is seldom a random quantity, and generalization is sought not
to an idealized “population of sites”, but instead to the actual popula-
tion. Thus, between-site variability is a nuisance that should either be
modeled by including random intercepts to accommodate different
site means, or be addressed through data harmonization, as discussed
above. Effects of interest, such as differences between individuals
with a specific condition and comparison individuals, can be assumed
to be fixed across sites (thus, would be modeled as a single regressor,
i.e., with fixed slopes), or assumed to vary across sites (thus, would be
modeled with multiple regressors, i.e., with random slopes), thus
implying the possibility of an interaction of site by effect of interest.
The latter would accommodate, for example, site differences due to
clinical characteristics or recruitment setting. Unwanted effects other
than the intercept can be modeled either considering fixed or random
slopes, the consideration being left on a per variable basis. For exam-
ple, age effects may be modeled using fixed slopes if all sites have par-
ticipants within similar age ranges, but using random slopes if some
sites have only young participants whereas others have only elderly,
as age is often not expected to have a linear effect across lifespan.
7.2 | Confounds
Unwanted data variability may arise due to procedural factors includ-
ing site or scanner features, or due to factors that affect both depen-
dent and independent variables. Variables representing the former
case are termed nuisance; those representing the latter, confounds.
Variables such as age or sex may be nuisance in some analyses or con-
founds in others, depending on the relationship between these vari-
ables and the other variables studied; here we broadly call nuisance
and confound variables covariates.
The large sample size of ENIGMA increases statistical power in
general, however, this may result in erroneous labeling confounding
effects (Smith & Nichols, 2018); ignoring such confounds may reduce
power or identify spurious associations. Addressing these concerns can
be challenging, as decisions regarding confounding variables affect
interpretation of the relationship between dependent and independent
variables (Gordon, 1968; Lord, 1967). For example, if a confounding var-
iable causes at least part of the variation observed in the imaging data
across participants and in the variation of the independent variable
(i.e., it is a collider), adjustment for the undesired effect induces a false
association (Berkson, 1946; Luque-Fernandez et al., 2019; Pearl, 2009,
chapter 6), which can happen in either direction (positive or negative).
Moreover, controlling for poorly reliable measures may not
completely remove their putative effects, leading to false conclusions
about effects (J. Westfall & Yarkoni, 2016). While this is a greater con-
cern for social and psychological constructs that often are measured
with relatively low reliability, the same can apply to imaging measure-
ments. Examples include segmentation of structures where tissue
contrast is minimal, or for structures that are small for the image reso-
lution; for functional MRI, false conclusions can occur through effects
of signal fluctuations that are poorly associated with task performance
or of weak functional connectivity among regions. All such measures
can produce variables that, if used as confounds, may increase the
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chance of false positives. Perhaps counterintuitively, here too large
sample sizes may exacerbate the problem.
A special kind of confound in brain imaging is a composite measure-
ment formed by pooling together values of all voxels/vertices or regions
of interest, with the goal of discounting unwanted global effects. For
example, in a vertexwise analysis of surface area, it might be of interest to
consider the total cortical surface area as a confounding variable. Like-
wise, for studies of subcortical volume, total brain size—or a related quan-
tity, the intracranial volume (Buckner et al., 2004)—can be considered a
confound; for cortical thickness, the average thickness across the cortex;
for functional MRI, at the subject level, a measurement of global signal,
though controversial, might be considered in a similar manner (Murphy &
Fox, 2017). The rationale for inclusion of a global measurement as a
regressor within the model stems from interest in enhancing the localizing
power afforded by imaging methods, and reducing sources of noise that
affect measures globally. From this perspective, the scientist seeks to
learn where, specifically, in the brain some phenomenon may occur. In
this context, arguably, global effects would be of lesser interest, unless a
research hypothesis is specifically about them. In addition, for functional
MRI, some sources of noise, such as movement and respiration, result in
artifactual global signal changes, and so removal of the global signal is also
an effective means of reducing artifacts (Ciric et al., 2017).
What makes these confounds special is that, being composites of
all other local (voxelwise/vertexwise) or regional quantities, they are
almost certainly correlated with these measurements, and thus, are
likely to also be associated with variables of interest in the model if
these are associated with the local or regional measurements. These
global variables are more likely to impact results where local or regional
effects of interest are present, even more so if these are widespread
across the brain. Options for taking into account such global effects in
the statistical analysis have been studied (Andersson, 1997; Barnes
et al., 2010; Nordenskjöld et al., 2013; Sanfilipo, Benedict, Zivadinov, &
Bakshi, 2004). The main approaches are: (a) convert each local or
regional measurement into a proportion over the global quantity;
(b) residualize the dependent variable with respect to the global; and
(c) include the global in the model. Among these three, the latter option
should always be favored as it accounts for effects that the con-
founding variable may have over both dependent and independent vari-
ables. The least preferable is the proportion method (a), one of the
reasons being that noisier (unreliable) measurements compromise the
measurements to a much greater extent than the others.
If confounding variables are meant to be included in the model, it
is often appropriate, considering all the above, to present results with
and without these variables in the model (Hyatt et al., 2020; Simmons
et al., 2011). Ideally, these would also be corrected for multiple test-
ing, as the number of opportunities for falsely significant results has
now doubled (see below more on multiple testing).
7.3 | Inference
Choices for inference can be broadly divided into parametric and non-
parametric. Parametric methods are computationally faster but require
assumptions that are sometimes difficult to justify. For example, data
have to be assumed to be independent and normally distributed with
identical variances after all nuisance variables and confounds have
been taken into account. These assumptions may hold for some ana-
lyses, but not for others. When the variety of imaging modalities pos-
sible for ENIGMA studies is considered, these assumptions cannot
hold for all of them. The consequence is that results will be incorrect
in at least some cases. Nonparametric tests, such as permutation tests,
on the other hand, require very few assumptions about the data prob-
ability distribution, and therefore can be applied to a wider variety of
situations than parametric tests. For permutation tests, the only key
assumption is that any random instantiation of permuted data must
be as likely to have been observed as the original, unpermuted. In
other words, the data must be exchangeable. If exchangeability holds,
permutation tests are exact, in the sense that the probability of
observing a p-value smaller than a predefined significance level α is α
itself when there are no true effects (Holmes, Blair, Watson, &
Ford, 1996; T. E. Nichols & Holmes, 2002; Winkler, Ridgway, Web-
ster, Smith, & Nichols, 2014).
For ENIGMA mega-analyses, permutation tests can pose practical
challenges, though. Large sample sizes and the multiplicity of sites,
combined with modeling that include random slopes and random
intercepts for covariates, leads to large design matrices that can be
slow to process repeatedly as needed for permutations. Moreover,
unless data have been harmonized in ways that accommodate poten-
tial different variances across sites, statistics that are robust to
heteroscedasticity (DiCiccio & Romano, 2017; Guillaume, Hua,
Thompson, Waldorp, & Nichols, 2014; Winkler et al., 2014) can like-
wise add to the computational burden; here, permutations may be
restricted to blocks of exchangeable observations that have been col-
lected within each site or within scanner. Another increase in compu-
tational expense occurs if more powerful, yet nonstandard test
statistics, such as pseudo-t (T. E. Nichols & Holmes, 2002), or spatial
statistics such as cluster extent, cluster mass, or threshold-free cluster
enhancement (TFCE) (Smith & Nichols, 2009) are used. In all these
cases, speed can be increased using fast, parallel implementation of
permutation algorithms (Eklund, Dufort, Villani, & Laconte, 2014), or
using accelerations based on various mathematical and statistical
properties of these same tests (Winkler, Ridgway, et al., 2016),
or both.
7.4 | Multiple testing
As with any imaging experiment that uses one statistical test per
imaging element (voxel, vertex, ROI), correction for multiple testing is
necessary (T. Nichols & Hayasaka, 2003). For parametric inference,
and under a series of additional assumptions, it is possible to control
the familywise error rate (FWER) using the RFT (Worsley et al., 1996);
methods and software exist for both voxelwise and vertexwise data.
However, this method cannot be used for ROIs, as these cannot be
represented as a regular lattice, or for voxelwise data that do not
meet all the assumptions of the theory, such as tract-based spatial
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statistics (Smith et al., 2006). A valid approach for all these cases, but
that controls a different error quantity, is the false discovery rate
(FDR) (Benjamini & Hochberg, 1995; Genovese, Lazar, &
Nichols, 2002). For permutation inference, correction for multiple
testing that controls the FWER can be accomplished in a straightfor-
ward manner for all the above cases using the distribution of the max-
imum statistic obtained across all tests in each permutation
(P. H. Westfall & Young, 1993). Uncorrected permutation p-values
can also be subjected to FDR correction.
Correction should consider not only the multiplicity of imaging
elements as voxels or ROIs, but also the multiple imaging-derived
measurements eventually tested in the same ENIGMA study
(e.g., cortical thickness and cortical area), as well as multiple hypothe-
ses formulated in terms of contrasts of parameters of the model
(Alberton, Nichols, Gamba, & Winkler, 2019), or multiple models for
the same data, for example, with and without a global measurement
as confounding variable. Failing to consider these issues exposes a
study to the risk of excess false positives. Correcting across multiple
tests for multiple hypotheses in the same study is challenging with
parametric tests given the existing but invariably unknown depen-
dence structure among tests; Bonferroni correction, while valid, is
unduly conservative given that dependence. Correction using the dis-
tribution of the maximum statistic, assessed via permutations, solves
the problem, regardless of the dependence structure, yielding exact
results, thus that are neither conservative (thus not less powerful
given the multiplicity of tests) nor invalid.
8 | REPORTING RESULTS
Classical meta-analyses results are often reported with the aid of for-
est plots (Borenstein et al., 2009), which show effect sizes and confi-
dence intervals for each study separately (or for each site in the case
of ENIGMA), along with a combined effect size that considers the
effects from all studies after some sensible weighting. ENIGMA stud-
ies that used meta-analyses adopted a similar approach where possi-
ble, for example, when imaging metrics were collapsible into single
numbers, such as asymmetry (Guadalupe et al., 2017; Kong
et al., 2018) or indices for specific structures (Hibar et al., 2015; Stein
et al., 2012). For mega-analyses, while such plots may be of lesser
value as the ultimate conclusions come from pooling all IPD into a sin-
gle analysis, reporting forest plots may still be helpful for showing
potentially distinct effects at each site, as well as identifying outlier
sites and qualitatively revealing how disperse the data are. However,
for this purpose, the mega-analysis may need to be broken down into
separate analyses, one per site, or contrasts tested separately for each
site in the case of random slopes (which accommodate interactions of
effects of interest by site). While these two approaches are equivalent
if there are no fixed slopes or fixed intercept anywhere in the model,
running analyses separately for each site is computationally less inten-
sive (and can be done in parallel in a straightforward manner).
Voxelwise and vertexwise results cannot, however, be feasibly shown
with forest plots, and the usual, color-coded maps for effect sizes
and/or p-values in logarithmic scale become then necessary, one per
site, as well as for the overall results.
8.1 | Authorship
Given the large number of involved sites and investigators, authorship
of published reports are an important aspect of ENIGMA projects.
While there are no enforceable rules to determine the authorship of a
scientific paper, a number of organizations have provided guidelines
and recommendations intended to ensure that substantial contributors
are credited as authors; for a review, see (Claxton, 2005). One such
organization is the International Committee of Medical Journal Editors
(ICMJE, also known as the “Vancouver group”), which recommends that
authorship are based on the following four criteria: (a) substantial contri-
butions to the conception or design of the work; or the acquisition,
analysis, or interpretation of data for the work; (b) drafting the work or
revising it critically for important intellectual content; (c) final approval
of the version to be published; (d) agreement to be accountable for all
aspects of the work in ensuring that questions related to the accuracy
or integrity of any part of the work are appropriately investigated and
resolved. It is recommended that all four conditions are satisfied. More-
over, all authors should be able to identify which co-authors are respon-
sible for other specific parts of the work (ICMJE, 2019).
Most ENIGMA studies have tried as much as possible to adhere to
these recommendations. For example, while not all investigators from all
sites may contribute directly to the planning or execution of the meta- or
mega-analysis, intellectual formulation of research hypotheses and study
design that led to the data collection at a given site often are the same for
which the data or results were pooled across multiple ENIGMA sites,
which, together with data collection itself, satisfies the first criterion. Col-
laborative, real-time text editing tools, such as Google Docs,22 Authorea,23
and Overleaf,24 allow many authors to work simultaneously on the same
document, editing and providing each other with comments, thus satisfy-
ing the second and third criterion. The fourth recommended criterion may
be satisfied implicitly through the communication established during the
editing process, by assenting upon the publication of a preprint, at a time
in which an author may choose to opt out before submission to a journal
and where eventual rectifications are more complex, or by signing a form
in which sugh agreement is made explicit. ENIGMA working group mem-
bers who do not satisfy the Vancouver criteria may be presented with
alternatives, such as (a) be named under a consortium author if they
worked on overarching conception of the project but not on the specific
paper, (b) be named in the Acknowledgments section of the paper, or
(c) not named; in the absence of guidelines, participating members are free
to choose what best represents their contribution.
9 | MEGA-ANALYSIS IN THE ENIGMA-GAD
GROUP
Having discussed the above, we are now in a position to better
describe the specifics of the ENIGMA-GAD analyses. In this group,
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sites were contacted based on their publication and funding record
using imaging data of subjects with a history of anxiety disorders, and
who could meet criteria for GAD. Virtually all sites that were con-
tacted and that did have structural imaging data were able to partici-
pate. While imaging offers a large range of measurements, the group
began by examining structural, T1-weighted imaging scans and per-
forming an analysis based on FreeSurfer. These choices reflected the
popularity of these scans, which are nearly universally collected,
regardless of other imaging modalities that each site may have used
for their investigations. Furthermore, FreeSurfer-based pipelines and
quality control protocols were already available from previous
ENIGMA studies. Having these as a starting point facilitated the
establishment of a new working group.
As described above, IPD were made available by the participating
sites to the coordinating facility—in this case, the National Institute of
Mental Health (NIMH), part of the US National Institutes of Health
(NIH)—such that a mega-analysis could be conducted. While the supe-
riority of mega-analyses is established, another factor was the propor-
tion of sites contributing IPD: nearly all sites preferred to send raw,
anonymized imaging scans, as opposed to individual level processed
data or simply summary results. Another early decision involved
preregistering the analytic plan, which was deposited at the Open Sci-
ence Foundation, where it remains publicly accessible.25 The plan was
registered after data had been received by the NIMH and processed
using FreeSurfer, such that sample sizes were known (eventually
more sites could contribute data after overcoming institutional bar-
riers; these were included in the analysis), and before statistical ana-
lyses. Data from some sites may have been part of previous
publications; the team analyzing the data at the coordinating facility
did not deliberately check the existence of previous results, nor
whether previous analyses on subsets used similar or different
methods. Instead, inclusion and exclusion criteria for data were
based on diagnoses given to the subjects in relation to the research
hypotheses, and the ability of the sites to make their data available
to the coordinating facility. In the preregistered plan, research
hypotheses were specified, inclusion and exclusion criteria were
defined, dependent and independent variables were indicated, and
statistical methods outlined. Exploratory analyses that were not the
main focus of the study were also listed.
A de-identification agreement was signed between the NIMH
and each participating center whereby any eventual identifiable data
would not be disclosed or requested by any of the parties. De-
identified data were transferred using the Globus service to a stor-
age partition of the high performance computing (HPC) systems of
the NIH. Each site had its own endpoint for transfer, such that no
information of any kind could leak from one contributing site to
another.
The received data were organized according to BIDS, passed
through an initial quality check using MRIQC, and processed using the
FreeSurfer 6.0.0. Given the large number of subjects, it was not viable
to follow the ENIGMA-QC26 protocol, according to which every corti-
cal parcel and every subcortical region of every participant would
need to be visually inspected and annotated where usable or not, so
as to give a mark “pass” or “fail.” This process would require an excess
of person-hours not available to the group. Instead, a semi-automated
method was used. First, a script27 to quickly allow visual inspection of
FreeSurfer cortical surfaces and subcortical segmentations of many
subjects in a single report page was used (Figure 4). One of the bene-
fits is that, by showing many subjects at the same time, the page per-
mits one to quickly learn how good quality surface and segmentations
should look like. Reconstructions with clear defects that grossly
affected anatomy were marked for exclusion by a single researcher
for all the data; all other reconstructions were, at this stage, not yet
marked for exclusion. Second, from the results of FreeSurfer, the
Euler characteristic of the surfaces before topology was obtained (it is
stored in the log file “recon-all.log”), as well as the number of vertices
of these surfaces. Receiver operating characteristic curves relating
variation on the Euler characteristic threshold and the ability to reject
the surfaces marked for exclusion after visual inspection were con-
structed so as to identify site-specific thresholds. Ultimately, the Euler
characteristic was replaced by the ratio between the Euler character-
istic and the number of vertices in the surfaces before topology cor-
rection, as this measure had a better ability to discriminate between
good and bad surfaces in this dataset. Finally, the identified threshold
was used to determine which subjects would be included and which
would not, on a per site basis.
Measurements considered for analyses, as indicated in the pre-
registration and as in previous ENIGMA studies, included cortical
measurements of thickness and surface area for each of the parcels of
the Desikan–Killiany atlas (Desikan et al., 2006), as well as volumes of
subcortical structures. Cortical vertexwise thickness and surface area
were also measured, and downsampled to the resolution of an icosa-
hedron recursively subdivided four times, with 2,562 vertices per
hemisphere. Because sites differed widely in variables such as age,
modeling age with random slopes (with additional quadratic effects)
seemed more appropriate than merely assuming that, across all ages
and sites, age effects would be exactly the same. Models with and
without a global measure (total surface area, average thickness, and
intracranial volume) were considered. Correction for multiple testing
used the distribution of the maximum statistic, assessed via permuta-
tions. ComBat was not used for the main analyses; instead, scanner-
specific effects were modeled (random intercepts) and a test statistic
robust to heteroscedasticity was used, along with variance groups
(one per site) and exchangeability blocks. ComBat is, however, being
assessed with the same data as a potential option for future studies;
results will be reported opportunely. Statistical analysis for this mega-
analysis used the tool Permutation Analysis of Linear Models
(PALM).28 At the time of this writing, the analysis is being finished and
the manuscript is being prepared for publication (Harrewijn et al., in
prep.). Authorship, like with the present paper, was defined according
to Vancouver criteria, generally with early career investigators, mem-
bers of the coordinating facility and who worked directly with the
data handling and the bulk of the writing appearing first, and with lead
investigators appearing last; in between, the contributing sites in
alphabetic order, and, within each site, early investigators appearing
first; lead investigators last.
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10 | CONCLUSION
This overview described the analytic choices across the various stages
of an ENIGMA mega-analysis, setting out the reasoning behind these
choices. Aspects related to data protection and privacy, and how to
handle confounds, along with other challenges that inevitably occur
when large-scale data from multiple sites are analyzed were also dis-
cussed. The various choices made by ENIGMA-GAD when facing each
of the discussed topics were presented. The hope is that the resulting
survey of these practical considerations will be useful to others
embarking on similar multi-site neuroimaging studies, especially those
integrating data across multiple countries and data modalities.
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